Safety and Efficacy of Mechanical Versus Electrocautery Dilator for EUS-guided Biliary Drainage (MED-BD)
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The MED-BD clinical trial is exploring two methods for treating a condition called biliary obstruction, where the bile ducts are blocked. Specifically, the study is comparing two types of tools used to help clear these blockages: a mechanical dilator and an electrocautery dilator. The main goal is to find out if one method causes less bleeding after the procedure than the other, with the belief that the mechanical method may be safer.
To participate in this trial, individuals need to be between 65 and 74 years old and have already had difficulties with a standard procedure called ERCP. They should not have certain health issues that could complicate treatment, such as serious bleeding disorders or pregnancy. The study is not yet recruiting participants, but if someone is eligible, they can expect to be closely monitored during the trial to ensure their safety and gather important information on how well each method works. This trial could help provide better treatment options for patients facing biliary obstructions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Failed ERCP
- • The papilla is inaccessible owing to a surgically altered anatomy or gastric outlet obstruction
- • Contraindications for PTCD such as ascites and possibility of self-tube removal
- Exclusion Criteria:
- • Patients younger than 18 years old
- • Cancer infiltration of the gastric/duodenal wall within the planned puncture route
- • Patients with uncorrectable coagulopathy
- • Patients with unmanageable ascites
- • Patients with serious comorbidities that prohibited endoscopic management
- • Patients with pregnancy
- • Patients who cannot or refuse to provide informed consent
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei City, , Taiwan
Patients applied
Trial Officials
Hsiu-Po Wang
Study Director
National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported